Medlive (2192.HK) traded up 3.55 % during a 24 hours period ending at 07:31 PM Central Europe on Monday 26th. One Medlive stock can currently be bought for about HKD 6.36 on popular exchanges. Current supply of Medlive stocks is 739.9 mn. Medlive has a current market capitalization of HKD 4.8 bn and approximately HKD 4.2 mn worth of Medlive was traded on exchanges in the last 24 hours. Since last month end, Medlive has traded -6.75 % down. Simple moving average of last 200 days is at HKD 8.29. The highest price of past 52 weeks was recorded at HKD 15.01 on 01/13/2026. 52 weeks low was at HKD 6.12 on 10/23/2026.

Here is how related stocks have performed in the past 24 hours:

  • Q (1478.HK) traded up 1.93 % and now trades at HKD 4.66. Q has a market capitalisation of HKD 5.7 bn. Current price/earnings ratio for Q is 3.3.

  • Zhuzhou Tianqiao Crane (002523.SZ) traded flat 0 % and now trades at CNY 3.31. Zhuzhou Tianqiao Crane has a market capitalisation of CNY 4.8 bn. Current price/earnings ratio for Zhuzhou Tianqiao Crane is 33.19.

  • Chongqing Port L (600279.SS) traded flat 0 % and now trades at CNY 4.05. Chongqing Port L has a market capitalisation of CNY 4.8 bn. Chongqing Port L has a current price to earnings ratio of 72.61.

  • Sino-high China (301076.SZ) traded flat 0 % and now trades at CNY 20.52. Current market capitalisation for Sino-high China is CNY 4.8 bn. Current price/earnings ratio for Sino-high China is 74.9. SINO‑HIGH CHINA CO LTD announced a revision to its upcoming capital‑raising plan, adjusting the upper limit for its share issuance to a larger number of shares while simultaneously reducing the maximum amount of capital to be raised. The company confirmed that its planned investment in a high‑performance resin and composite production project will receive a smaller share of the newly raised funds, citing a shift in project scope. The remaining portions of the investment program will continue to receive the same level of funding. This change reflects a reallocation of resources toward a more focused production line for PEEK resin and related facilities, while other composite production initiatives will rely on internal or externally sourced capital. The announcement highlights a strategic adjustment aimed at optimizing the company’s financial structure and project implementation.

  • Utour (002707.SZ) traded flat 0 % and now trades at CNY 4.94. Utour has a market capitalisation of CNY 4.8 bn.

About Medlive

Medlive Technology Co., Ltd. is an online professional physician platform operating in the health care sector with its base in Beijing, China. The company provides a vast range of medical information such as clinical guidelines, medical conferences, case readings, diagnosis and treatment knowledge base, and other medical information. MedLive Technology services are available exclusively in China.